This study demonstrates the unique clinical and histologic aspects of fibrolamellar hepatic carcinoma, a rare variant of hepatocellular carcinoma. Three cases are reviewed and an extensive study of immunologic and intracellular substances defining this tumor is presented. Length of survival was considerably longer than typical hepatoma. The cause of death generally is due to a lack of control of the primary tumor. Successful treatment appears to relate to the ability to perform a total excision of the primary hepatic tumor. Chemotherapy should be used only in the presence of metastatic disease. Surgical resection of metastatic disease, unlike the usual hepatocarcinoma, may have some beneficial use. Fibrinogen was found in all tumors. It is possible that this tumor produces fibrinogen to create its unique histologic appearance. Carcinoembryonic antigen is described for the first time in this tumor. Both deposits of alpha-1 antitrypsin and copper were found in most of the tissues studied. The presence and amounts of these substances differ markedly from the common type of hepatoma. This unique composition of intracellular components may both facilitate histologic diagnosis, particularly if the amount of tissue is limited, and give further insight into the etiology of this tumor. F IBROLAMELLAR CARCINOMA (FLC), a variant of hepatocellular carcinoma (HCC) comprises less than one per cent of cases in most series of HCC.'*' Only 43 cases of FLC have been described in a review of the world literature. The distinct morphology was originally described by Edmonson in 1958: "It consists of polygonally-shaped tumor cells with a highly eosinophilic cytoplasm. Bands of fibrous stroma, arranged in parallel lamellae, surround clusters of these tumor cells. The clinical aspects of these tumors differ significantly from the typical trabecular type of HCC. The tumor predominates in adolescents and young adults; the incidences between males and females are equal; and usually no 
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past history of cirrhosis or exposure to hepatitis B virus (HBV) is given."' The prognosis for such a patient is considerably good; average survivals for FLC compared to other primary liver tumors are 44 to 68 months and 6 months, re~pective1y.l~~ Because of the relative rarity of this tumor, little or no literature is available on the clinical management of these patients. Recent attempts to study this tumor have used both electron microscopy and several special staining techniquesS4 Vitamin BI2 binding protein in FLC tumor cells may be a characteristic marker.' In addition, the presence of intracytoplasmic copper and copper-binding protein, in one case reports6 and fibrinogen7 may also be associated with the tumor. Such associations, however, are hampered by the rarity of this tumor.
This report presents three new cases of FLC found in a review of 58 patients with a diagnosis of HCC from 1966 to 1981. The clinical cases are reviewed, as is the gross and microscopic histology. A discussion of surgical and nonsurgical management is given. In addition, the most extensive investigation to date of the presence of specific antigens and other markers in FLC is presented. A highly sensitive immunoperoxidase technique was employed, along with other special stains from the study, the results of which add to the present knowledge of this tumor.
Materials and Methods
All tissue was fixed in 10% buffered formalin and parafin embedded. Immunohistochemical localization of fibrinogen, carcinoembryonic antigen (CEA), alphafetoprotein (AFP), alpha-1 -antitrypsin (A-1 -AT), hepatitis B surface antigen (HB,A,), and human blood group antigens A, B, and H (0) was accomplished with an
